0001104659-23-021541.txt : 20230214 0001104659-23-021541.hdr.sgml : 20230214 20230214160615 ACCESSION NUMBER: 0001104659-23-021541 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230210 FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jin David CENTRAL INDEX KEY: 0001930732 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35366 FILM NUMBER: 23628887 MAIL ADDRESS: STREET 1: C/O AVENUE THERAPEUTICS, INC. STREET 2: 1140 AVENUE OF THE AMERICAS, FLOOR 9 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fortress Biotech, Inc. CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 FORMER COMPANY: FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC DATE OF NAME CHANGE: 20080310 4 1 tm236803-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-02-10 0 0001429260 Fortress Biotech, Inc. FBIO 0001930732 Jin David C/O FORTRESS BIOTECH, INC. 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 0 1 0 0 Chief Financial Officer COMMON STOCK, PAR VALUE $0.001 2023-02-10 4 P 0 35928 0.835 A 1438757 D The total holdings include 1,350,000 shares underlying deferred restricted stock units. /s/ David Jin 2023-02-14